Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CEBP Focus Archive
    • Meeting Abstracts
    • Progress and Priorities
    • Collections
      • COVID-19 & Cancer Resource Center
      • Disparities Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Informing Public Health Policy
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Epidemiology, Biomarkers & Prevention
Cancer Epidemiology, Biomarkers & Prevention
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CEBP Focus Archive
    • Meeting Abstracts
    • Progress and Priorities
    • Collections
      • COVID-19 & Cancer Resource Center
      • Disparities Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Informing Public Health Policy
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Null Results in Brief

Risk Factors for Pancreatic Cancer Mortality: Extended Follow-up of the Original Whitehall Study

G. David Batty, Mika Kivimaki, David Morrison, Rachel Huxley, George Davey Smith, Robert Clarke, Michael G. Marmot and Martin J. Shipley
G. David Batty
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mika Kivimaki
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Morrison
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rachel Huxley
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
George Davey Smith
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert Clarke
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael G. Marmot
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Martin J. Shipley
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1158/1055-9965.EPI-08-1032 Published February 2009
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Given the well-established links between diabetes and elevated rates of pancreatic cancer, there are reasons to anticipate that other markers of metabolic abnormality (increased body mass index, plasma cholesterol, and blood pressure) and their correlates (physical activity and socioeconomic status) may also confer increased risk. However, to date, the results of a series of population-based cohort studies are inconclusive. We examined these associations in the original Whitehall cohort study of 17,898 men. A maximum of 38 years of follow-up gave rise to 163 deaths due to carcinoma of the pancreas. Although Poisson regression analyses confirmed established risk factor–disease associations for increasing age, smoking, and type II diabetes, there was essentially no evidence that body mass index (rate ratio, 1.01; 95% confidence interval per 1 SD increase, 0.86-1.18), plasma cholesterol (0.91; 0.78-1.07), diastolic blood pressure (0.93; 0.78-1.09), systolic blood pressure (0.98; 0.83-1.15), physical activity (sedentary versus high: 1.37; 0.89-2.12), or socioeconomic status [clerical (low) versus professional/executive, 0.95; 0.59-1.51] offered any predictive value for pancreatic cancer mortality. These results were unchanged following control for a range of covariates. (Cancer Epidemiol Biomarkers Prev 2009;18(2):673–5)

  • epidemiology
  • pancreatic cancer
  • risk factors

Introduction

Pancreatic cancer is a relatively rare malignancy but a major cause of cancer mortality worldwide (1, 2). With conventional treatments essentially ineffective (3), <4% of cases survive 5 years after diagnosis (4, 5). Despite the crucial importance of primary prevention for such a near-lethal neoplasm, little is known about its risk factors beyond increased age, family history, smoking, and diabetes (3). Obesity and physical activity, by dint of their link with diabetes, have been implicated in pancreatic cancer etiology, but findings suggest that any increased occurrence of this neoplasm in the obese may be modest (6), particularly in men (7), and evidence for physical exertion is inconclusive with both inverse (8, 9) and null (10-12) associations reported. Other metabolic abnormalities such as increased levels of blood pressure (13-15) and blood cholesterol (15-17), although examined in few studies, generally show no effect. Furthermore, the evidence that socioeconomic disadvantage, by which all of the afore described risk factors are patterned, may confer increased risk of carcinoma of the pancreas is uncertain with opposing gradients reported (10, 18).

We contribute to this highly inconclusive and scant literature, much of which is derived from underpowered studies, by focusing on the role of obesity, physical activity, increased blood pressure, elevated plasma cholesterol, and socioeconomic disadvantage as potential risk factors for pancreatic cancer in an extended follow-up of a large prospective cohort of male office workers.

Materials and Methods

In the Whitehall Study, data were collected on 19,019 male, nonindustrial, government employees with ages from 40 to 69 years at the time of examination between 1967 and 1970 in London (United Kingdom), representing a 77% response (19). This involved the completion of a study questionnaire and participation in a medical examination, both of which have been described in detail elsewhere (19). In brief, the questionnaire included inquiries regarding civil service employment grade (an indicator of socioeconomic status; ref. 20), smoking habits (21), marital status (22), and physical activity (23, 24). Blood pressure (13), height (25), weight (26), pulmonary function (indexed by forced expiratory volume in 1 s; ref. 27), and, following an overnight fast, plasma cholesterol (17) and post-challenge blood glucose concentration (28) were all determined using standard protocols (19). Body mass index was computed using the standard formula [weight (kg) / height2 (m2)].

A total of 18,863 men (99.2% of participants in the baseline survey) were traced using the U.K. National Health Service Central Registry and pancreatic cancer deaths were ascertained from death certificates (coded as ICD 8/9: 157, ICD 10: C25). The present analyses are based on 17,898 men with complete data. The person years of follow-up for each man was partitioned by age at risk using 5-year age groups. To summarize the relationship between each risk factor and pancreatic cancer, we used Poisson regression, which produced rate ratios with accompanying 95% confidence intervals. These analyses were first adjusted for age at risk and then fully adjusted for all potential confounding and mediating factors.

Results

During a maximum of 38 years of follow-up, there were 12,797 deaths from all causes in the present analytical sample, 163 (1.3%) of which were ascribed to pancreatic cancer. We were able to replicate the few well-established risk factor–disease associations for pancreatic cancer. Thus, in age-adjusted analyses, current (rate ratio, 1.52; 95% confidence interval, 0.94-2.46) and former smokers (1.72; 1.07-2.77) relative to nonsmokers, and men with type II diabetes (2.47; 0.79-7.75) relative to those who were free of this condition, all experienced an elevated risk of this malignancy. Age itself also revealed the expected positive association with pancreatic cancer mortality (rate ratio per 10-year increase, 2.10; 1.79-2.46).

In Table 1 , we show the associations between a series of other potential risk factors for carcinoma of the pancreas. Body mass index, plasma cholesterol, and socioeconomic position were all unrelated to pancreatic cancer risk. Similarly, neither component of blood pressure predicted the occurrence of this malignancy. There was a modest elevated risk in the least physically active men that, again, did not attain statistical significance at conventional levels, and there was no evidence of a dose-response effect across the exercise groups.

View this table:
  • View inline
  • View popup
Table 1.

Risk factors for pancreatic cancer mortality in the original Whitehall Study (N = 17,898)

Discussion

In this large prospective cohort study with almost complete follow-up of its members, there was little suggestion that a series of indicators of metabolic abnormalities or their correlates (all of which have been hypothesized, by us and other groups, to influence pancreatic cancer risk), actually revealed any relationship with this malignancy, either with or without adjustment for potential confounders. These results accord with the generally null findings from a series of studies for body mass index (in men) (ref. 7), plasma cholesterol (15-17), blood pressure (13-15), physical activity (10-12), and socioeconomic position (18)—including those from earlier follow-ups of the present cohort for some of these risk factors which were based on substantially fewer deaths (13, 20, 23, 26).

This study has several strengths, including its large sample size, which leads to a greater number of pancreatic cancer events than many other studies, prospective design, statistical control of a range of potential mediating and confounding variables, and almost complete follow-up for mortality. Weaknesses include the absence of measurement of other potential risk factors such as dietary characteristics, as well as alcohol and meat consumption (29). Although 3-day food intake diaries were in fact administered in the present study, this was only in a subset of fewer than 2,000 men (26) in which the number of pancreatic cancer deaths is too low to facilitate analyses. A second study limitation is the absence of repeat measurement of these risk factors over time, a common shortcoming in this field. However, given that this data set revealed the established risk factor–disease gradients for age, diabetes, and smoking in relation to pancreatic cancer, there is a suggestion that our null results should be trusted.

In conclusion, although confirming previously well-demonstrated risk factors-disease associations, we found little or no evidence that potentially modifiable physical characteristics (body mass index, plasma cholesterol, blood pressure, physical activity) or socioeconomic status were associated with pancreatic cancer mortality. Examination of other potential risk factors, including dietary characteristics, is important in order to increase our understanding of the etiology of pancreatic cancer and to identify targets for primary prevention.

Disclosure of Potential Conflicts of Interest

No potential conflicts of interest were disclosed.

Acknowledgments

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Footnotes

  • Grant support: The original screening of the Whitehall study was funded by the Department of Health and Social Security and the Tobacco Research Council. David Batty is a Wellcome Trust Fellow, Michael Marmot is a UK Medical Research Council Research Professor, Martin Shipley is supported by the British Heart Foundation, and Mika Kivimaki by the Academy of Finland.

    • Accepted November 7, 2008.
    • Received October 30, 2008.

References

  1. ↵
    Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74–108.
    OpenUrlCrossRefPubMed
  2. ↵
    Hariharan D, Saied A, Kocher HM. Analysis of mortality rates for pancreatic cancer across the world. HPB (Oxford) 2008;10:58–62.
    OpenUrlPubMed
  3. ↵
    Li D, Xie K, Wolff R, Abbruzzese JL. Pancreatic cancer. Lancet 2004;363:1049–57.
    OpenUrlCrossRefPubMed
  4. ↵
    Lowenfels AB, Maisonneuve P. Risk factors for pancreatic cancer. J Cell Biochem 2005;95:649–56.
    OpenUrlCrossRefPubMed
  5. ↵
    Sant M, Aareleid T, Berrino F, et al. EUROCARE-3: survival of cancer patients diagnosed 1990-94—results and commentary. Ann Oncol 2003;14 Suppl 5:v61–118.
    OpenUrlCrossRefPubMed
  6. ↵
    Berrington dG, Sweetland S, Spencer E. A meta-analysis of obesity and the risk of pancreatic cancer. Br J Cancer 2003;89:519–23.
    OpenUrlCrossRefPubMed
  7. ↵
    Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 2008;371:569–78.
    OpenUrlCrossRefPubMed
  8. ↵
    Michaud DS, Giovannucci E, Willett WC, Colditz GA, Stampfer MJ, Fuchs CS. Physical activity, obesity, height, and the risk of pancreatic cancer. JAMA 2001;286:921–9.
    OpenUrlCrossRefPubMed
  9. ↵
    Stolzenberg-Solomon RZ, Pietinen P, Taylor PR, Virtamo J, Albanes D. A prospective study of medical conditions, anthropometry, physical activity, and pancreatic cancer in male smokers (Finland). Cancer Causes Control 2002;13:417–26.
    OpenUrlCrossRefPubMed
  10. ↵
    Nilsen TI, Vatten LJ. A prospective study of lifestyle factors and the risk of pancreatic cancer in Nord-Trondelag, Norway. Cancer Causes Control 2000;11:645–52.
    OpenUrlCrossRefPubMed
  11. Stolzenberg-Solomon RZ, Adams K, Leitzmann M, et al. Adiposity, physical activity, and pancreatic cancer in the National Institutes of Health-AARP Diet and Health Cohort. Am J Epidemiol 2008;167:586–97.
    OpenUrlAbstract/FREE Full Text
  12. ↵
    Lin Y, Kikuchi S, Tamakoshi A, et al. Obesity, physical activity and the risk of pancreatic cancer in a large Japanese cohort. Int J Cancer 2007;120:2665–71.
    OpenUrlCrossRefPubMed
  13. ↵
    Batty GD, Shipley MJ, Marmot MG, Davey Smith G. Blood pressure and site-specific cancer mortality: evidence from the original Whitehall study. Br J Cancer 2003;89:1243–7.
    OpenUrlCrossRefPubMed
  14. Grove JS, Nomura A, Severson RK, Stemmermann GN. The association of blood pressure with cancer incidence in a prospective study. Am J Epidemiol 1991;134:942–7.
    OpenUrlAbstract/FREE Full Text
  15. ↵
    Ansary-Moghaddam A, Huxley R, Barzi F, et al. The effect of modifiable risk factors on pancreatic cancer mortality in populations of the Asia-Pacific region. Cancer Epidemiol Biomarkers Prev 2006;15:2435–40.
    OpenUrlAbstract/FREE Full Text
  16. Neaton JD, Blackburn H, Jacobs D, et al. Serum cholesterol level and mortality findings for men screened in the Multiple Risk Factor Intervention Trial. Multiple Risk Factor Intervention Trial Research Group. Arch Intern Med 1992;152:1490–500.
    OpenUrlCrossRefPubMed
  17. ↵
    Davey Smith G, Shipley MJ, Marmot MG, Rose G. Plasma cholesterol concentration and mortality. The Whitehall Study. JAMA 1992;267:70–6.
    OpenUrlCrossRefPubMed
  18. ↵
    van Loon AJ, Brug J, Goldbohm RA, van den Brandt PA, Burg J. Differences in cancer incidence and mortality among socio-economic groups. Scand J Soc Med 1995;23:110–20.
    OpenUrlPubMed
  19. ↵
    Reid DD, Hamilton PJS, McCartney P, et al. Cardiorespiratory disease and diabetes among middle-aged male civil servants. Lancet 1974;i:469–73.
  20. ↵
    Davey Smith G, Leon D, Shipley MJ, Rose G. Socioeconomic differentials in cancer among men. Int J Epidemiol 1991;20:339–45.
    OpenUrlAbstract/FREE Full Text
  21. ↵
    Batty GD, Kivimaki M, Gray L, Davey Smith G, Marmot MG, Shipley MJ. Cigarette smoking and site-specific cancer mortality: testing uncertain associations using extended follow-up of the original Whitehall study. Ann Oncol 2008;19:1002.
    OpenUrl
  22. ↵
    Ben Shlomo Y, Davey Smith G, Shipley M, Marmot MG. Magnitude and causes of mortality differences between married and unmarried men. J Epidemiol Community Health 1993;47:200–5.
    OpenUrlAbstract/FREE Full Text
  23. ↵
    Batty GD, Shipley M, Marmot M, Davey Smith G. Physical activity and cause-specific mortality in men: further evidence from the Whitehall study. Eur J Epidemiol 2002;17:863–9.
    OpenUrl
  24. ↵
    Davey Smith G, Shipley MJ, Batty GD, Morris JN, Marmot M. Physical activity and cause-specific mortality in the Whitehall study. Public Health 2000;114:308–15.
    OpenUrlPubMed
  25. ↵
    Batty GD, Shipley MJ, Langenberg C, Marmot MG, Davey Smith G. Adult height in relation to mortality from 14 cancer sites in men in London (UK): evidence from the original Whitehall study. Ann Oncol 2006;17:157–66.
    OpenUrlAbstract/FREE Full Text
  26. ↵
    Batty GD, Shipley MJ, Jarrett RJ, Breeze E, Marmot MG, Davey Smith G. Obesity and overweight in relation to organ-specific cancer mortality in London (UK): findings from the original Whitehall study. Int J Obes (Lond) 2005;29:1267–74.
    OpenUrlCrossRefPubMed
  27. ↵
    Batty GD, Gunnell D, Langenberg C, Davey Smith G, Marmot MG, Shipley MJ. Adult height and lung function as markers of life course exposures: associations with risk factors and cause-specific mortality. Eur J Epidemiol 2006;21:795–801.
    OpenUrlCrossRefPubMed
  28. ↵
    Batty GD, Shipley MJ, Marmot M, Davey Smith G. Diabetes status and post-load plasma glucose concentration in relation to site-specific cancer mortality: findings from the original Whitehall study. Cancer Causes Control 2004;15:873–81.
    OpenUrlCrossRefPubMed
  29. ↵
    Zheng W, McLaughlin JK, Gridley G, et al. A cohort study of smoking, alcohol consumption, and dietary factors for pancreatic cancer (United States). Cancer Causes Control 1993;4:477–82.
    OpenUrlCrossRefPubMed
View Abstract
PreviousNext
Back to top
Cancer Epidemiology Biomarkers & Prevention: 18 (2)
February 2009
Volume 18, Issue 2
  • Table of Contents
  • Table of Contents (PDF)

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Epidemiology, Biomarkers & Prevention article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Risk Factors for Pancreatic Cancer Mortality: Extended Follow-up of the Original Whitehall Study
(Your Name) has forwarded a page to you from Cancer Epidemiology, Biomarkers & Prevention
(Your Name) thought you would be interested in this article in Cancer Epidemiology, Biomarkers & Prevention.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Risk Factors for Pancreatic Cancer Mortality: Extended Follow-up of the Original Whitehall Study
G. David Batty, Mika Kivimaki, David Morrison, Rachel Huxley, George Davey Smith, Robert Clarke, Michael G. Marmot and Martin J. Shipley
Cancer Epidemiol Biomarkers Prev February 1 2009 (18) (2) 673-675; DOI: 10.1158/1055-9965.EPI-08-1032

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Risk Factors for Pancreatic Cancer Mortality: Extended Follow-up of the Original Whitehall Study
G. David Batty, Mika Kivimaki, David Morrison, Rachel Huxley, George Davey Smith, Robert Clarke, Michael G. Marmot and Martin J. Shipley
Cancer Epidemiol Biomarkers Prev February 1 2009 (18) (2) 673-675; DOI: 10.1158/1055-9965.EPI-08-1032
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Disclosure of Potential Conflicts of Interest
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • Diet Quality and Ovarian Cancer Survival
  • PDE5 inhibitors use and precursors of colorectal cancer
  • Association between serum iron biomarkers and breast cancer
Show more Null Results in Brief
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook   Twitter   LinkedIn   YouTube   RSS

Articles

  • Online First
  • Current Issue
  • Past Issues

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Epidemiology, Biomarkers & Prevention

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Epidemiology, Biomarkers & Prevention
eISSN: 1538-7755
ISSN: 1055-9965

Advertisement